This article was originally published in The Gray Sheet
Submits a premarket approval application for its Osteoport intraosseous vascular access device. Earlier this month, the firm confirmed the "substantial equivalence" of its new septum material to that formerly supplied by Dow Corning ("The Gray Sheet" July 12, In Brief).
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.